![]() |
![]() |
1,1&rsquo-{1-D-(1,3,5/2,4,6)-4-[5-deoxy-2-O-(2-deoxy-2-methylamino-α-L-glucopyranosyl)-3-C-formyl-α-L-lyxofuranosyloxy]-2,5,6-trihydroxycyclohex-1,3-ylene}diguanidine sulfate (2:3) (salt) 2-[(1S,2R,3S,4S,5R,6S)-5-(diaminomethylideneamino)-2-[(2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-methylamino-oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyl-oxolan-2-yl]oxy-3,4,6-trihydroxy-cyclohexyl]guanidine D-Streptamine, O-2-deoxy-2-(methylamino)-a-L-glucopyranosyl-(1->2)-O-5-deoxy-3-C-formyl-a-L-lyxofuranosyl-(1->4)-N,N'-bis(aminoiminomethyl)-, sulfate (2:3) EINECS 223-286-0 MFCD00037023 N,N'-[(1R,2R,3S,4R,5R,6S)-4-[[5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-formyl-α-L-lyxofuranosyl]oxy]-2,5,6-trihydroxy-1,3-cyclohexanediyl]bis[guanidine] sulfate (2:3) O-2-Deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1->2)-O-5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl-(1->4)-N,N'-bis(aminoiminomethyl)-D-streptamine sulfate O-2-Deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl-(1-4)-N,N'-bis(aminoiminomethyl)-D-Streptamine sulfate (2:3) salt O-2-deoxy-2-methylamino-α-L-glucopyranosyl-(1→2)-O-5-deoxy-3-C-formyl-α-L-lyxofuranosyl-(1→4)-N1,N3-diamidino-D-streptamine sulfate (2:3) (salt) Strep-sol Streptomyc Streptomycin 2/3 Sulfate Streptomycin (sulfate) Streptomycin sulfate salt Streptomycin Sulphate Verstrep
Moderately toxic by ingestion and subcutaneous routes. Human teratogenic effects by intramuscular route: developmental abnormalities of the eye and ear. When heated to decomposition it emits very toxic fumes of SOx and NOx. See also STREPTOMYCIN and SULFATES.
?Streptomycin sulfate , ever using CAS.:?298-39-5, its cas register number is 3810-74-0.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
hamster | LD50 | oral | 400mg/kg (400mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: FOOD INTAKE (ANIMAL) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Toxicology and Applied Pharmacology. Vol. 14, Pg. 510, 1969. |
infant | TDLo | intraperitoneal | 170mg/kg (170mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
British Medical Journal. Vol. 1, Pg. 557, 1961. |
mouse | LD50 | intravenous | 90200ug/kg (90.2mg/kg) | ? | Antibiotiki. Vol. 18, Pg. 444, 1973. |
mouse | LD50 | oral | 430mg/kg (430mg/kg) | ? | "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 106, 1982. |
mouse | LD50 | subcutaneous | 403mg/kg (403mg/kg) | ? | Antibiotics Annual. Vol. 4, Pg. 574, 1956/1957. |
rat | LD50 | oral | 430mg/kg (430mg/kg) | ? | "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 106, 1982. |
rat | LD50 | subcutaneous | 600mg/kg (600mg/kg) | ? | Arzneimittel-Forschung. Drug Research. Vol. 12, Pg. 597, 1962. |
?
Not classified.
Pictogram(s) | ![]() |
---|---|
Signal word | Warning |
Hazard statement(s) | H317 May cause an allergic skin reaction H335 May cause respiratory irritation |
Precautionary statement(s) | |
Prevention | none |
Response | none |
Storage | none |
Disposal | none |
none